Skip to content

Gastroesophageal Reflux and AF Recurrence After Ablation

Gastroesophageal Reflux and AF Recurrence After Ablation - AF and GERD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000060583
Enrollment
50
Registered
2026-02-05
Start date
2026-03-03
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Interventions

None listed

Sponsors

Shimane university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients scheduled to undergo catheter ablation for atrial fibrillation (AF). Patients aged 18 years or older at the time of informed consent. Patients who have provided written informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1) Patients with any of the following diseases: Esophageal cancer Pharyngeal cancer Gastric cancer Esophageal varices 2) Patients with any of the following conditions: Esophageal stricture

Design outcomes

Primary

MeasureTime frame
The primary outcome is changes in esophageal-related findings after atrial fibrillation ablation. The secondary outcome is atrial fibrillation recurrence, recorded based on routine clinical practice.

Countries

Japan

Contacts

Public ContactYumi Nagira

Shimane University Hospital Division of cardiology

yumina@med.shimane-u.ac.jp0853232111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026